R&D Systems™ Recombinant Human CD96v2 Fc Chimera Protein

Catalog No.	Quantity
9556CD050	50 μg

Catalog No. 9556CD050 Supplier R&D Systems™ Supplier No. 9556CD050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

Measured by its binding ability in a functional ELISA. When Recombinant Human CD155/PVR Fc Chimera (Catalog # 9174-CD ) is immobilized at 1 μg/mL, 100 μL/well, the concentration of Recombinant Human CD96 v2 Fc Chimera that produces 50% of the optimal binding response is 30-150 ng/mL.

Specifications

• Accession Number: P40200-2
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 10225
• Molecular Weight (g/mol): M.W. (Observed): 132-152 kDa, reducing conditions; M.W. (theoretical): 80 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human CD96 protein Human CD96 (Lys25-Met503) (N-terminus) Accession # P40200-2 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Alias: CD96, CD96 antigenMGC22596, CD96 molecule, DKFZp667E2122, T cell-activated increased late expression protein, TACTILE, TACTILEincreased late expression, T-cell surface protein tactile
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: CD96